{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T22:19:25Z","timestamp":1785709165915,"version":"3.56.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.toxlet.2004.08.002","type":"journal-article","created":{"date-parts":[[2004,9,28]],"date-time":"2004-09-28T18:37:14Z","timestamp":1096396634000},"page":"201-216","source":"Crossref","is-referenced-by-count":14,"title":["Estimation of interindividual variation in oxidative metabolism of dichloromethane in human volunteers"],"prefix":"10.1016","volume":"154","author":[{"given":"Lisa M.","family":"Sweeney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Kirman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Morgott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Gargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2004.08.002_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1539-6924.1993.tb00730.x","article-title":"Pharmacokinetic modeling of trichloroethylene and trichloroacetic acid in humans","volume":"13","author":"Allen","year":"1993","journal-title":"Risk Anal."},{"key":"10.1016\/j.toxlet.2004.08.002_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0041-008X(87)90281-X","article-title":"Physiologically based pharmacokinetics and the risk assessment process for methylene chloride","volume":"87","author":"Andersen","year":"1987","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.toxlet.2004.08.002_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0041-008X(91)90264-F","article-title":"Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans","volume":"108","author":"Andersen","year":"1991","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.toxlet.2004.08.002_bib4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5271\/sjweh.2852","article-title":"Exposure to methylene chloride. I. Its concentration in alveolar air and blood during rest and exercise and its metabolism","volume":"1","author":"\u00c5strand","year":"1975","journal-title":"Scand. J. Work Environ. Health"},{"key":"10.1016\/j.toxlet.2004.08.002_bib5","series-title":"Nonlinear Parameter Estimation","author":"Bard","year":"1974"},{"key":"10.1016\/j.toxlet.2004.08.002_bib6","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s002040050016","article-title":"CYP2E1 expression in bone marrow and its intra- and interspecies variability: approaches for a more reliable extrapolation from one species to another in the risk assessment of chemicals","volume":"73","author":"Bernauer","year":"2000","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2004.08.002_bib7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00420-002-0407-4","article-title":"The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine","volume":"76","author":"Bolt","year":"2003","journal-title":"Int. Arch. Occup. Environ. Health"},{"key":"10.1016\/j.toxlet.2004.08.002_bib8","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1021\/ac00195a023","article-title":"Estimating error limits in parametric curve fitting","volume":"61","author":"Caceci","year":"1989","journal-title":"Anal. Chem."},{"key":"10.1016\/j.toxlet.2004.08.002_bib9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1539-6924.1994.tb00268.x","article-title":"Sensitivity of physiologically based phramacokinetic models to variation in model parameters: methylene chloride","volume":"14","author":"Clewell","year":"1994","journal-title":"Risk Anal."},{"key":"10.1016\/j.toxlet.2004.08.002_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0300-483X(95)03038-H","article-title":"Incorporating biological information in quantitative risk assessment: an example with methylene chloride","volume":"102","author":"Clewell","year":"1995","journal-title":"Toxicology"},{"key":"10.1016\/j.toxlet.2004.08.002_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/toxsci\/49.1.15","article-title":"A physiological model for tert-amyl methyl ether and tert-amyl alcohol: hypothesis testing of model structures","volume":"49","author":"Collins","year":"1999","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2004.08.002_bib12","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0009-2797(01)00204-6","article-title":"Toxicokinetics of inhaled and endogenous isoprene in mice, rats, and humans","volume":"135\u2013136","author":"Csanady","year":"2001","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.toxlet.2004.08.002_bib13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1079\/BJN19910073","article-title":"Body mass index as a measure of body fatness: age- and sex-specific prediction formulas","volume":"65","author":"Deurenberg","year":"1991","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.toxlet.2004.08.002_bib14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev.pharmtox.43.100901.140251","article-title":"Human extrahepatic cytochrome P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts","volume":"43","author":"Ding","year":"2003","journal-title":"Ann. Rev. Toxicol."},{"key":"10.1016\/j.toxlet.2004.08.002_bib15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0041-008X(81)90460-9","article-title":"Uptake, metabolism, and elimination of methylene chloride vapor by humans","volume":"59","author":"DiVincenzo","year":"1981","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.toxlet.2004.08.002_bib16","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1006\/rtph.2001.1469","article-title":"Using human data to protect the public's health","volume":"33","author":"Dourson","year":"2001","journal-title":"Reg. Toxicol. Pharmacol."},{"key":"10.1016\/j.toxlet.2004.08.002_bib17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0378-4274(95)03566-4","article-title":"Toxicokinetic models for volatile industrial chemicals and reactive metabolites","volume":"82\u201383","author":"Filser","year":"1995","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2004.08.002_bib18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0041-008X(86)90196-1","article-title":"Metabolism of inhaled dihalomethanes in vivo: differentiation of kinetic constants for two independent pathways","volume":"82","author":"Gargas","year":"1986","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.toxlet.2004.08.002_bib19","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.2307\/2291566","article-title":"Physiological pharmacokinetic analysis using population modeling and informative prior distributions","volume":"91","author":"Gelman","year":"1996","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.toxlet.2004.08.002_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-4274(02)00408-3","article-title":"Mechanistic and toxicokinetic data reducing uncertainty in risk assessment","volume":"138","author":"Greim","year":"2003","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2004.08.002_bib21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00228-003-0566-6","article-title":"Cytochrome P4502E1 (CYP2E1) expression in peripheral blood lymphocytes: evaluation in hepatitis C and diabetes","volume":"59","author":"Haufroid","year":"2003","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.toxlet.2004.08.002_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01062190","article-title":"Sensitivity analysis for physiologically based pharmacokinetic models","volume":"19","author":"Hetrick","year":"1991","journal-title":"J. Pharamcokin. Biopharm."},{"key":"10.1016\/j.toxlet.2004.08.002_bib23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1124\/jpet.102.053124","article-title":"Human hepatic CYP2E1 expression during development","volume":"307","author":"Johnsrud","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.toxlet.2004.08.002_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0378-4274(02)00369-7","article-title":"The Bayesian population approach to physiological toxicokinetic\u2013toxicodynamic models\u2014an example using the MCSim software","volume":"138","author":"Jonsson","year":"2003","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2004.08.002_bib25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1006\/taap.2001.9206","article-title":"A Bayesian analysis of the influence of GSTT1 polymorphism on the cancer risk estimate for dichloromethane","volume":"174","author":"Jonsson","year":"2001","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.toxlet.2004.08.002_bib26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/toxsci\/59.2.209","article-title":"Physiologically based pharmacokinetic modeling of inhalation exposure of humans to dichloromethane during moderate to heavy exercise","volume":"59","author":"Jonsson","year":"2001","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2004.08.002_bib27","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2174\/1566524033479609","article-title":"CYP2E1: biochemistry, toxicology, regulation and function in ethanol-induced liver injury","volume":"3","author":"Kessova","year":"2003","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.toxlet.2004.08.002_bib28","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/toxsci\/49.2.172","article-title":"Quantitative evaluation of alternative mechanisms of blood and testes disposition of di(2-ethylhexyl) phthalate and mono(2-ethylhexyl) phthalate in rats","volume":"49","author":"Keys","year":"1999","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2004.08.002_bib29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/toxsci\/kfg212","article-title":"Tissue dosimetry expansion and cross-validation of rat and mouse physiologically based pharmacokinetic models for trichloroethylene","volume":"76","author":"Keys","year":"2003","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2004.08.002_bib30","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0009-9236(95)90227-9","article-title":"Interindividual variability of chlorzoxazone 6-hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphisms","volume":"57","author":"Kim","year":"1995","journal-title":"Clin Pharmacol. Ther."},{"key":"10.1016\/j.toxlet.2004.08.002_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/toxsci\/62.2.191","article-title":"A physiologically based pharmacokinetic model for methyl tert-butyl ether in humans: implementing sensitivity and variability analyses","volume":"62","author":"Licata","year":"2001","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2004.08.002_bib32","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1152\/physrev.1997.77.2.517","article-title":"Cytochrome P-4502E1: its physiological and pathological role","volume":"77","author":"Lieber","year":"1997","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.toxlet.2004.08.002_bib33","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.pharmtox.41.1.535","article-title":"Interindividual variability in inhibition and induction of cytochrome P450 enzymes","volume":"41","author":"Lin","year":"2001","journal-title":"Ann. Rev. Toxicol."},{"key":"10.1016\/j.toxlet.2004.08.002_bib34","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.0272-4332.2003.00397.x","article-title":"The impact of cytochrome P450 2E1-dependent metabolic variance on a risk-relevant pharmacokinetic outcome in humans","volume":"23","author":"Lipscomb","year":"2003","journal-title":"Risk Anal."},{"key":"10.1016\/j.toxlet.2004.08.002_bib35","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00008571-199906000-00013","article-title":"Chlorzoxazone, a selective probe for phenotyping CYP2E1 in humans","volume":"9","author":"Lucas","year":"1999","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.toxlet.2004.08.002_bib36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0378-4274(00)00287-3","article-title":"Cytochrome CYP2E1 phenotyping and genotyping in the evaluation of health risks from exposure to polluted environments","volume":"124","author":"Lucas","year":"2001","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2004.08.002_bib37","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1248\/yakushi.123.369","article-title":"Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR","volume":"123","author":"Nishimura","year":"2003","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.toxlet.2004.08.002_bib38","unstructured":"Occupational Safety and Health Administration (OSHA), 1997. Occupational exposure to methylene chloride\u2014final rule. Federal Register. 10 January, 1997, 29 CFR parts 1910, 1915, and 1926, pp. 1494\u20131611."},{"key":"10.1016\/j.toxlet.2004.08.002_bib39","unstructured":"Office of Environmental Health Hazard Assessment (OEHHA), 2000. Public health goals for chemicals in drinking water\u2014dichloromethane (methylene chloride, DCM). California Environmental Protection Agency."},{"key":"10.1016\/j.toxlet.2004.08.002_bib40","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/978-3-642-74117-3_55","article-title":"Dichloromethane metabolism to carbon monoxide can be induced by isoniazid, acetone and fasting","volume":"14","author":"Pankow","year":"1989","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2004.08.002_bib41","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0272-0590(89)90290-X","article-title":"Variability of safe dose estimates when using complicated models of the carcinogenic process","volume":"13","author":"Portier","year":"1989","journal-title":"Fund. Appl. Toxicol."},{"key":"10.1016\/j.toxlet.2004.08.002_bib42","first-page":"1429","article-title":"Human lymphocyte cytochrome P450 2E1, a putative marker for alcohol-mediated changes in hepatic chlorzoxazone activity","volume":"25","author":"Raucy","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxlet.2004.08.002_bib43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0378-4274(88)90023-9","article-title":"Incorporation of in vitro enzyme data into the physiologically based pharmacokinetic (PB-PK) model for methylene chloride: implications for risk assessment","volume":"43","author":"Reitz","year":"1988","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2004.08.002_bib44","doi-asserted-by":"crossref","first-page":"29632","DOI":"10.1074\/jbc.270.50.29632","article-title":"Ethanol induces CYP2E1 by protein stabilization. Role of ubiquitin conjugation in the rapid degradation of CYP2E1","volume":"270","author":"Roberts","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxlet.2004.08.002_bib45","article-title":"Dose-dependant transitions in mechanisms of toxicity","author":"Slikker","year":"2004","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.toxlet.2004.08.002_bib46","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1006\/rtph.2000.1424","article-title":"Interindividual variance of cytochrome P450 forms in human hepatic microsomes: correlation of individual forms with xenobiotic metabolism and implications in risk assessment","volume":"32","author":"Snawder","year":"2000","journal-title":"Reg. Toxicol. Pharmacol."},{"key":"10.1016\/j.toxlet.2004.08.002_bib47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/toxsci\/71.1.27","article-title":"Physiologically based pharmacokinetic model parameter estimation and sensitivity and variability analyses for acrylonitirile disposition in humans","volume":"71","author":"Sweeney","year":"2003","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2004.08.002_bib48","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1289\/ehp.96104858","article-title":"PBPK modeling\/Monte Carlo simulation of methylene chloride kinetic changes in mice in relation to age and acute, subchronic, and chronic inhalation exposure","volume":"8","author":"Thomas","year":"1996","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.toxlet.2004.08.002_bib49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s002280050164","article-title":"Interindividual variability in catalytic activity and immunoreactivity of three major human liver cytochrome P450 isozymes","volume":"51","author":"Transon","year":"1996","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.toxlet.2004.08.002_bib50","unstructured":"US Environmental Protection Agency (USEPA), 1992. Draft report: a cross-species scaling factor for carcinogen risk assessment based on equivalence of mg\/kg3\/4\/day. Federal Register 57, pp. 24152\u201324173."},{"key":"10.1016\/j.toxlet.2004.08.002_bib51","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/oem.53.9.601","article-title":"Comparison of average estimated metabolic rates for styrene in previously exposed and unexposed groups with pharmacokinetic modelling","volume":"53","author":"Wang","year":"1996","journal-title":"Occup. Environ. Med."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427404003984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427404003984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T06:48:08Z","timestamp":1585896488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427404003984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0378427404003984"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2004.08.002","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}